Yong Xu | Cartilage Tissue | Best Researcher Award

Posted on by Pencis

Dr. Yong Xu | Cartilage Tissue | Best Researcher Award

Tongji University | China

Author Profile

Scopus

✨ XU YONG: A PIONEER IN TUMOR TREATMENT AND TISSUE REPAIR ✨

🎓 EARLY ACADEMIC PURSUITS

Xu Yong was born on May 29, 1991, in Fuzhou, Jiangxi, and pursued a career in medicine from an early age. He embarked on his academic journey at Tongji University School of Medicine, where he obtained his Bachelor of Clinical Medicine (2010-2015). With a keen interest in thoracic surgery and tissue engineering, he continued his education at Shanghai Pulmonary Hospital, earning a Master's Degree in Thoracic Surgery (2015-2018). His academic dedication led him to pursue a Ph.D. in Thoracic Surgery (2018-2021) at the same institution, where he developed expertise in tumor treatment and tissue repair.

🌟 PROFESSIONAL ENDEAVORS

Following his Ph.D., Xu Yong joined Shanghai Pulmonary Hospital as a Resident Physician (2021-2024), where he honed his clinical skills in thoracic surgery and tissue engineering. In August 2024, he transitioned to a research-focused role as a Special Associate Researcher at the Nuclear Industry 416 Hospital, Provincial Clinical Medical Research Center. His work in this position is instrumental in advancing innovative solutions for tracheal tissue engineering and regenerative medicine.

⚖️ CONTRIBUTIONS AND RESEARCH FOCUS ON CARTILAGE TISSUE

Xu Yong’s research primarily revolves around tissue engineering for cartilage regeneration, with a strong emphasis on functional tracheal reconstruction. His groundbreaking work introduced the "ring strategy", which enables the construction of bionic tracheal tissue with an alternating cartilage ring-connective tissue ring arrangement. This strategy successfully demonstrated long-term functional reconstruction of long-segment tracheal defects in rabbit models.

⚛️ MAJOR RESEARCH PROJECTS

Xu Yong has been the Principal Investigator (PI) in multiple prestigious projects, including:

  • Shanghai Science and Technology Rising Star Project (2024-2027): Focused on high-bionic tracheal tissue engineering (400,000 RMB).
  • Youth Talent Support Project (2023-2025): Dedicated to tracheal tissue engineering (300,000 RMB).
  • National Natural Science Foundation of China (2024-2026): Developing simulated tracheal tissue for large animal models (300,000 RMB).
  • Shanghai Natural Science Foundation (2022-2025): Advancing the construction of bioengineered trachea (200,000 RMB).

Additionally, he is a key participant in a major project funded by the National Natural Science Foundation of China (2,150,000 RMB), focusing on the precise matching of multiple cell types for bionic construction of long-segment trachea.

✨ IMPACT AND INFLUENCE

Xu Yong’s contributions have significantly influenced the field of tissue engineering and regenerative medicine, particularly in tracheal defect repair. His innovative biomimetic tracheal tissue construction has paved the way for improved clinical applications in treating long-segment tracheal defects. His research bridges the gap between basic science and clinical translation, offering promising therapeutic solutions for thoracic surgery.

🏆 ACADEMIC CITATIONS AND PUBLICATIONS

Xu Yong has an impressive publication record, contributing to over 30 SCI papers with a cumulative impact factor exceeding 300. His key achievements include:

  • 20 papers as first/co-first author
  • 14 papers as corresponding/co-corresponding author
  • 15 papers with an impact factor greater than 10
  • Highest single impact factor: 27.4

Notable journals where his research has been published:

  • Advanced Materials (ADV MATER)
  • Advanced Functional Materials (Adv. Funct. Mater.)
  • Advanced Science (Adv Sci.)
  • Composites Part B: Engineering (COMPOS PART B-ENG)
  • International Journal of Bioprinting (INT J BIOPRINTING)

Additionally, he holds over 10 patents related to tissue engineering and regenerative medicine.

🎬 LEGACY AND FUTURE CONTRIBUTIONS

Xu Yong’s pioneering efforts in tracheal tissue engineering and tumor treatment have established a new benchmark in the field. His ring strategy has set the foundation for future research in biomimetic tracheal reconstruction. Moving forward, he aims to:

  • Advance clinical translation of biomimetic tracheal tissue into human trials.
  • Explore novel biomaterials and tissue engineering scaffolds.
  • Collaborate on interdisciplinary projects integrating AI-driven biomaterial development.

His contributions will continue to shape the future of thoracic surgery, offering lifesaving solutions for patients with severe tracheal defects.

✨ CONCLUSION

Xu Yong is a trailblazer in regenerative medicine and thoracic surgery, whose dedication to tissue engineering and tracheal reconstruction has the potential to revolutionize the field. With a solid foundation in research, clinical expertise, and a vision for innovation, he is poised to make lasting contributions to modern medicine.

📑 NOTABLE PUBLICATIONS 

"Cartilage structure-inspired nanofiber-hydrogel composite with robust proliferation and stable chondral lineage-specific differentiation function to orchestrate cartilage regeneration for artificial tracheal construction" 

  • Authors: Y., Li, Yaqiang , X., Xun, Xiaowei , L., Duan, Liang , Y., Xu, Yong , H., Xia, Huitang
  • Journal: Bioactive Materials
  • Year: 2025

"Polydopamine-loaded microneedles for sequential tumor ablation and osteochondral regeneration" 

  • Authors: B., Lin, Bin , Y., Xu, Yong , B., Liang, Bing
  • Journal: Materials Letters
  • Year: 2025

"Copper hydrogen phosphate nanosheets functionalized hydrogel with tissue adhesive, antibacterial, and angiogenic capabilities for tracheal mucosal regeneration" 

  • Authors: P., Wang, Pengli , E., Gao, Erji , T., Wang, Tao , C., Yang, Chen , L., Duan, Liang
  • Journal: Journal of Nanobiotechnology
  • Year: 2024

"3D printing of Ceffe-infused scaffolds for tailored nipple-like cartilage development" 

  • Authors: J., Ding, Jinghao , C., Wei, Chuanzhi , Y., Xu, Yong , W., Dai, Wufei , R., Chen, Ru
  • Journal: BMC Biotechnology
  • Year: 2024

"Injectable and self-healing sulfated hyaluronic acid/gelatin hydrogel as dual drug delivery system for circumferential tracheal repair" 

  • Authors: Y., Yang, Yayan , X., Zhu, Xinsheng , X., Liu, Xuezhe , N., Song, Nan , Q., Feng, Qian
  • Journal: International Journal of Biological Macromolecules
  • Year: 2024

Yulia Desheva | Immunology | Best Researcher Award

Posted on by Pencis

Dr. Yulia Desheva | Immunology | Best Researcher Award

Institute of Experimental Medicine | Russia

Author Profile

Scopus 

Orcid ID

🌟 Biography of Yulia Desheva 🌟

EARLY ACADEMIC PURSUITS 🎓

Yulia Desheva demonstrated an exceptional aptitude for the sciences early in her academic journey, culminating in advanced degrees in virology and immunology. Her academic focus honed in on understanding the molecular mechanisms underlying viral infections, particularly influenza. This foundation provided her with the skills to innovate within vaccine development and immunization strategies. Her dedication to research began in St. Petersburg, Russia, where she laid the groundwork for her contributions to global virology.

PROFESSIONAL ENDEAVORS 💼

As a Senior Scientist at the Institute of Experimental Medicine and a professor at St. Petersburg State University, Yulia Desheva plays a pivotal role in advancing vaccine research. Her professional career spans leadership roles in virology, where she collaborates with global institutions like Academia Sinica in Taiwan. She is a valued member of the International Society for Influenza and Other Respiratory Virus Diseases (ISIRV) and contributes to scientific journals as a reviewer for Virology Journal, Journal of Infection and Public Health, and more.

CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNOLOGY🧪

Desheva’s groundbreaking work centers on vaccine development and viral-bacterial interactions. Her achievements include:

  • Development of live influenza vaccines tailored for high-risk individuals.
  • Creation and evaluation of mucosal vaccines addressing viral-bacterial infections and COVID-19.
  • Studying neuraminidase antibodies to advance immunization efficacy.
    Her innovative approach to developing vaccines for avian influenza viruses has positioned her as a leader in the field. Additionally, her research focuses on reducing bacterial complications arising from influenza infections through novel vaccine designs.

IMPACT AND INFLUENCE 🌍

Yulia Desheva's contributions extend beyond her laboratory to impact global public health. Her research has:

  • Enhanced vaccine accessibility for high-risk populations.
  • Influenced global strategies for managing pandemics and viral outbreaks.
  • Strengthened scientific collaboration across international borders.

Her role as a mentor has also nurtured the next generation of scientists, ensuring her legacy within virology and immunology.

ACADEMIC CITATIONS 📚

  • Books Published: 2
  • Peer-Reviewed Articles: 54 (published in SCI and Scopus-indexed journals)
  • Citation Index: 10

These metrics reflect her dedication to advancing scientific knowledge in virology and vaccine development.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

With 20 patents to her name and numerous ongoing research projects, Yulia Desheva is poised to continue driving innovations in vaccine science. Her collaborative work with global institutions ensures her contributions will remain at the forefront of addressing emerging infectious diseases. She is committed to creating safer and more effective vaccines for future generations, cementing her legacy as a pioneer in immunology.

HIGHLIGHTS OF PROFESSIONAL ACHIEVEMENTS 🌟

  • Patents: 20
  • Completed/Ongoing Projects: 20
  • Editorial Roles: Reviewer for leading journals in virology and public health.
  • International Collaborations: Academia Sinica, Taiwan.

Desheva’s relentless pursuit of innovation and her interdisciplinary approach continue to inspire advancements in science and medicine.

NOTABLE PUBLICATIONS 📑

"Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity" 

  • Authors: Desheva, Y. , Lerner, A. , Shvedova, T. , Leontieva, G. , Suvorov, A.
  • Journal: Antibodies
  • Year: 2023

"Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis" 

  • Authors: Desheva, Y. , Petkova, N. , Losev, I. , Chao, Y.-C. , Tsai, C.-H.
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

"Immune Response and Laboratory markers in the Spectrum of Severity of COVID-19" 

  • Authors: Desheva, Y.A. , Shvedova, T.N. , Kudar, P.А. , Petrachkova, D.S. , Lerner, A.A.
  • Journal: Medicine Academic Journal
  • Year: 2023

"Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years" 

  • Authors: Desheva, Y. , Losev, I. , Petkova, N. , Tsai, C.-H. , Chao, Y.-C.
  • Journal: Pharmaceuticals
  • Year: 2022

"Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice" 

  • Authors: Desheva, Y. , Leontieva, G. , Kramskaya, T. , Kudar, P. , Suvorov, A.
  • Journal: Microorganisms
  • Year: 2022